Session 1: “Impact of Recent Clinical Trials on the Management of Neovascular AMD”
April 25, 2021
- Describe how clinical trial results differentiate treatments based on functional, anatomic, and visual outcomes
- Sequence and combine therapies appropriately based on response to anti-VEGF and other patient-specific factors
This activity is supported by an independent medical education grant from Alcon Vision, LLC, Novartis, Regeneron Pharmaceuticals, and RegenexBio.